Kevin Williams is the Chief Medical Officer (CMO) for Pfizer Rare Disease. In this role, he leads a Medical Affairs organization of approximately 150 medical colleagues around the globe supporting Pfizer’s efforts and portfolio in Rare Disease. Dr. Williams joined Pfizer in January 2004 as a Director, Regional Medical & Research Specialists working in the HIV disease area. After moving into a Team Leader position in July 2005, he has served in various leadership roles during his career at Pfizer, most recently as the Global Medical Affairs Vice President for Rare Disease in Pfizer’s Global Innovative Pharma business unit where he supervised a group of global colleagues providing medical leadership and strategic support for inline and pipeline assets in Endocrinology, Hematology, TTR-Amyloidosis, Gaucher’s Disease, and other rare diseases. Dr. Williams moved into his current Rare Disease CMO position in May 2016.
Kevin received his medical degree from the UCLA School of Medicine and is board-certified in Internal Medicine. He spent eight years in private practice caring for HIV positive patients. In addition to his medical degree, Kevin has a Master’s Degree in Public Health from the UCLA School of Public Health and a Juris Doctorate from Harvard Law School.